Benchling acquires PipeBio to accelerate AI-powered antibody discovery
We’re excited to announce Benchling’s acquisition of PipeBio, a leader in high-throughput bioinformatics analysis to drive biologics discovery.
Filter by
Filter by
Category
Clear all
No results matched your search.
Clear your search and remove filters for better results.
Clear all
Powering breakthroughs for over 1,200 biotechnology companies, from startups to Fortune 500s
